Similar articles for PMID: 27092233

Year	Number of Results
1981	1
1984	1
1985	1
1989	2
1990	1
1991	1
1993	3
1994	1
1995	2
1996	2
1997	2
1998	5
1999	3
2000	7
2001	1
2002	4
2003	3
2004	2
2005	4
2006	1
2008	1
2009	2
2010	1
2012	1
2013	2
2014	3
2015	3
2016	3
2017	1
2018	3
2019	3
2020	1
2024	0

1

Glibenclamide-induced profound hypoglycaemic crisis: a case report.

Hussain A, Ali I, Khan AU, Khan TM. Hussain A, et al. Ther Adv Endocrinol Metab. 2016 Apr;7(2):84-7. doi: 10.1177/2042018816632440. Epub 2016 Feb 17. Ther Adv Endocrinol Metab. 2016. PMID: 27092233 Free PMC article.

2

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP. Plosker GL, et al. Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.

3

Drug-induced disorders of glucose metabolism. Mechanisms and management.

Chan JC, Cockram CS, Critchley JA. Chan JC, et al. Drug Saf. 1996 Aug;15(2):135-57. doi: 10.2165/00002018-199615020-00005. Drug Saf. 1996. PMID: 8884164 Review.

4

Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.

Vos RC, van Avendonk MJ, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GE. Vos RC, et al. Cochrane Database Syst Rev. 2016 Sep 18;9(9):CD006992. doi: 10.1002/14651858.CD006992.pub2. Cochrane Database Syst Rev. 2016. PMID: 27640062 Free PMC article. Review.

5

Comparative tolerability profiles of oral antidiabetic agents.

Krentz AJ, Ferner RE, Bailey CJ. Krentz AJ, et al. Drug Saf. 1994 Oct;11(4):223-41. doi: 10.2165/00002018-199411040-00002. Drug Saf. 1994. PMID: 7848543 Review.

6

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.

van Dalem J, Brouwers MC, Stehouwer CD, Krings A, Leufkens HG, Driessen JH, de Vries F, Burden AM. van Dalem J, et al. BMJ. 2016 Jul 13;354:i3625. doi: 10.1136/bmj.i3625. BMJ. 2016. PMID: 27413017 Free PMC article.

7

Management of antidiabetic medications in overdose.

Spiller HA. Spiller HA. Drug Saf. 1998 Nov;19(5):411-24. doi: 10.2165/00002018-199819050-00007. Drug Saf. 1998. PMID: 9825953 Review.

8

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

Jackson JE, Bressler R. Jackson JE, et al. Drugs. 1981 Sep;22(3):211-45. doi: 10.2165/00003495-198122030-00003. Drugs. 1981. PMID: 7021124 Review.

9

Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.

Holstein A, Egberts EH. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2003 Oct;111(7):405-14. doi: 10.1055/s-2003-44287. Exp Clin Endocrinol Diabetes. 2003. PMID: 14614647 Review.

10

Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.

Holstein A, Plaschke A, Ptak M, Egberts EH, El-Din J, Brockmöller J, Kirchheiner J. Holstein A, et al. Br J Clin Pharmacol. 2005 Jul;60(1):103-6. doi: 10.1111/j.1365-2125.2005.02379.x. Br J Clin Pharmacol. 2005. PMID: 15963101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year